1. Home
  2. AGEN vs CURV Comparison

AGEN vs CURV Comparison

Compare AGEN & CURV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agenus Inc.

AGEN

Agenus Inc.

N/A

Current Price

$7.71

Market Cap

274.8M

Sector

Health Care

ML Signal

N/A

Logo Torrid Holdings Inc.

CURV

Torrid Holdings Inc.

N/A

Current Price

$2.48

Market Cap

237.3M

ML Signal

N/A

Company Overview

Basic Information
Metric
AGEN
CURV
Founded
1994
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Clothing/Shoe/Accessory Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
274.8M
237.3M
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
AGEN
CURV
Price
$7.71
$2.48
Analyst Decision
Strong Buy
Hold
Analyst Count
3
7
Target Price
★ $26.33
$2.17
AVG Volume (30 Days)
★ 1.1M
160.7K
Earning Date
11-09-2026
09-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 100.00
N/A
EPS
★ 0.96
0.06
Revenue
$42,877,086.00
★ $1,000,092,000.00
Revenue This Year
$9.64
N/A
Revenue Next Year
N/A
$1.63
P/E Ratio
★ $7.85
$39.33
Revenue Growth
★ 89.95
N/A
52 Week Low
$2.71
$0.94
52 Week High
$10.19
$2.86

Technical Indicators

Market Signals
Indicator
AGEN
CURV
Relative Strength Index (RSI) 46.32 55.27
Support Level $6.51 $2.45
Resistance Level $8.64 $2.52
Average True Range (ATR) 0.63 0.13
MACD -0.18 0.01
Stochastic Oscillator 14.75 69.35

Price Performance

Historical Comparison
AGEN
CURV

About AGEN Agenus Inc.

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.

About CURV Torrid Holdings Inc.

Torrid Holdings Inc is a direct-to-consumer brand in North America dedicated to offering a diverse assortment of stylish apparel, intimates, and accessories skillfully designed for curvy women. Its extensive collection features high-quality merchandise, including tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of its e-Commerce platform and stores.

Share on Social Networks: